We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+18.48%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$748M
AUM Growth
+$11.5M
(+1.6%)
Cap. Flow
-$43.9M
Cap. Flow
% of AUM
-5.86%
Top 10 Holdings %
Top 10 Hldgs %
21.83%
Holding
143
New
43
Increased
23
Reduced
42
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wingstop
WING
|
+$15.2M |
| 2 |
Calix
CALX
|
+$14.5M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$13.2M |
| 4 |
Deckers Outdoor
DECK
|
+$10.5M |
| 5 |
Booz Allen Hamilton
BAH
|
+$9.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SiTime
SITM
|
+$17.1M |
| 2 |
Halozyme
HALO
|
+$15.4M |
| 3 |
Littelfuse
LFUS
|
+$13.6M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$12.7M |
| 5 |
Dave & Buster's
PLAY
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.34% |
| 2 | Healthcare | 26.27% |
| 3 | Industrials | 20.62% |
| 4 | Consumer Staples | 10.04% |
| 5 | Consumer Discretionary | 8.96% |
Similar funds
GF
PIM
EH
TPWA
ECA
DL
STT
VC
Lisanti Capital Growth's Q3 2022 Portfolio in Review
As of Q3 2022, Lisanti Capital Growth held 143 positions worth $748M, up 1.6% from $736M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lisanti Capital Growth withdrew a net $43.9M in Q3 2022, closing 33 positions and reducing 42 holdings. Its most notable exit was SiTime, an estimated $17.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Lisanti Capital Growth opened a new position in Wingstop worth $15.9M.
- Lisanti Capital Growth's largest Q3 2022 buy was Wingstop: 126,975 shares worth $15.9M.
- Lisanti Capital Growth added most to Advanced Drainage Systems in Q3 2022, an estimated $8.48M increase.
- Lisanti Capital Growth's biggest Q3 2022 reduction was Intra-Cellular Therapies Inc., cutting an estimated $12.7M.
- Lisanti Capital Growth fully exited SiTime in Q3 2022, selling an estimated $17.1M.
- Lisanti Capital Growth's ten largest holdings make up 22% of its $748M portfolio in Q3 2022.
- Lisanti Capital Growth opened 43 new positions and closed 33 in Q3 2022.
- Lisanti Capital Growth's portfolio value rose 1.6% quarter-over-quarter to $748M.
Based on Lisanti Capital Growth's 13F filing for Q3 2022, filed 2 Nov 2022.